Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer with poor
prognosis. Surgery, chemotherapy, and radiofrequency ablation are three conventional …

Introduction Immunotherapy has recently taken on an extremely important role in medical
oncology, as first-or later-line treatment in several tumor types, and recent years have seen …

Glioblastoma multiforme (GBM) is the most malignant intracranial tumor in adults,
characterized by extensive infiltrative growth, high vascularization, and resistance to multiple …

Simple Summary Personalized neoantigen vaccines are a diverse group of personally
tailored cancer vaccines that strengthen patients´ own immune reaction against cancer …

The immune system is composed of immune organs, immune cells, and immunoactive
substances, which plays a vital role in antitumor immunity in cancer immunotherapy. During …

The emergence of non-alcoholic fatty liver disease (NAFLD) as the leading chronic liver
disease worldwide raises some concerns. In particular, NAFLD is closely tied to sedentary …

Intercellular crosstalk among various liver cells plays an important role in liver fibrosis,
cirrhosis, and hepatocellular carcinoma (HCC). Capillarization of liver sinusoidal endothelial …

Primary liver cancer is the second leading cause of tumor-related deaths in China, with
hepatocellular carcinoma (HCC) accounting for 80%–90% of these. Since there is a lack of …

Objective Several new first-line treatments were recently approved for unresectable
hepatocellular carcinoma (HCC). In this meta-analysis, we compare the efficacy and safety …

Objectives Both combinations of the PARP inhibitor veliparib plus platinum doublet
chemotherapy (CT), and the programmed death receptor-1 (PD-1) inhibitor nivolumab plus …